```json
{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "W",
          "alt": "STOP",
          "position": "453"
        },
        "variant_string_id": "PARK2 W453STOP"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper focuses on understanding the mechanisms of parkin inactivation in autosomal recessive Parkinson's disease (ARPD). The disease mechanism involves loss of parkin function, leading to accumulation of parkin substrates and subsequent neuronal damage.",
          "judgment": "Yes",
          "reasoning": "The paper directly addresses the disease mechanism by investigating how mutations lead to loss of parkin function, a known cause of ARPD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses detergent solubility assays, cellular localization studies, and ubiquitination assays to assess the impact of mutations on protein folding, aggregation, membrane association, and E3 ligase activity. These assays are relevant for understanding how parkin mutations disrupt its normal function.",
          "judgment": "Yes",
          "reasoning": "The assays used (protein solubility, cellular localization, ubiquitination) are directly relevant to assessing parkin's function and how mutations affect it in the context of ARPD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper included wild-type parkin as a negative control and some experiments were done in triplicate, as indicated in figure legends.",
          "judgment": "Yes",
          "reasoning": "Wild-type parkin provides a normal/negative control. The text does not explicitly state replicates were performed for all experiments, but for some replicates were stated",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study used W453Stop as a positive control in some assays. The paper also mentions other pathogenic mutations such as E409Stop and Q311Stop.",
          "judgment": "Yes",
          "reasoning": "The paper used known pathogenic variants W453Stop, E409Stop, and Q311Stop as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "The study included quantitative analysis of the detergent-soluble and insoluble fractions, and statistical significance was not directly assessed.",
          "judgment": "No",
          "reasoning": "Statistical analyses sufficient to calculate OddsPath were not performed in the paper.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Several pathogenic variants (W453Stop, E409Stop, Q311Stop, A1-79, R42P, R33Q, K48A, V56E) were used in the study. 8 variants total.",
          "judgment": "Yes",
          "reasoning": "The study includes fewer than 11 pathogenic and benign variant controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The W453STOP variant shows a clear pathogenic effect through multiple lines of evidence, including misfolding, aggregation, and reduced E3 ligase activity, and well-established controls are used. However, due to limited statistical analysis and the total number of controls being less than 11, the strength is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "E",
          "alt": "STOP",
          "position": "409"
        },
        "variant_string_id": "PARK2 E409STOP"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper focuses on understanding the mechanisms of parkin inactivation in autosomal recessive Parkinson's disease (ARPD). The disease mechanism involves loss of parkin function, leading to accumulation of parkin substrates and subsequent neuronal damage.",
          "judgment": "Yes",
          "reasoning": "The paper directly addresses the disease mechanism by investigating how mutations lead to loss of parkin function, a known cause of ARPD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses detergent solubility assays, cellular localization studies, and ubiquitination assays to assess the impact of mutations on protein folding, aggregation, membrane association, and E3 ligase activity. These assays are relevant for understanding how parkin mutations disrupt its normal function.",
          "judgment": "Yes",
          "reasoning": "The assays used (protein solubility, cellular localization, ubiquitination) are directly relevant to assessing parkin's function and how mutations affect it in the context of ARPD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper included wild-type parkin as a negative control and some experiments were done in triplicate, as indicated in figure legends.",
          "judgment": "Yes",
          "reasoning": "Wild-type parkin provides a normal/negative control. The text does not explicitly state replicates were performed for all experiments, but for some replicates were stated",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study used W453Stop as a control, and also analyzes other pathogenic mutations such as E409Stop.",
          "judgment": "Yes",
          "reasoning": "The paper used W453Stop and E409Stop as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "The study included quantitative analysis of the detergent-soluble and insoluble fractions, and statistical significance was not directly assessed.",
          "judgment": "No",
          "reasoning": "Statistical analyses sufficient to calculate OddsPath were not performed in the paper.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Several pathogenic variants (W453Stop, E409Stop, Q311Stop, A1-79, R42P, R33Q, K48A, V56E) were used in the study. 8 variants total.",
          "judgment": "Yes",
          "reasoning": "The study includes fewer than 11 pathogenic and benign variant controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The E409STOP variant shows a clear pathogenic effect through multiple lines of evidence, including misfolding and aggregation, and well-established controls are used. However, due to limited statistical analysis and the total number of controls being less than 11, the strength is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "Q",
          "alt": "STOP",
          "position": "311"
        },
        "variant_string_id": "PARK2 Q311STOP"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper focuses on understanding the mechanisms of parkin inactivation in autosomal recessive Parkinson's disease (ARPD). The disease mechanism involves loss of parkin function, leading to accumulation of parkin substrates and subsequent neuronal damage.",
          "judgment": "Yes",
          "reasoning": "The paper directly addresses the disease mechanism by investigating how mutations lead to loss of parkin function, a known cause of ARPD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses detergent solubility assays, cellular localization studies, and ubiquitination assays to assess the impact of mutations on protein folding, aggregation, membrane association, and E3 ligase activity. These assays are relevant for understanding how parkin mutations disrupt its normal function.",
          "judgment": "Yes",
          "reasoning": "The assays used (protein solubility, cellular localization, ubiquitination) are directly relevant to assessing parkin's function and how mutations affect it in the context of ARPD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper included wild-type parkin as a negative control and some experiments were done in triplicate, as indicated in figure legends.",
          "judgment": "Yes",
          "reasoning": "Wild-type parkin provides a normal/negative control. The text does not explicitly state replicates were performed for all experiments, but for some replicates were stated",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study used W453Stop as a control, and also analyzes other pathogenic mutations such as Q311Stop.",
          "judgment": "Yes",
          "reasoning": "The paper used W453Stop and Q311Stop as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "The study included quantitative analysis of the detergent-soluble and insoluble fractions, and statistical significance was not directly assessed.",
          "judgment": "No",
          "reasoning": "Statistical analyses sufficient to calculate OddsPath were not performed in the paper.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Several pathogenic variants (W453Stop, E409Stop, Q311Stop, A1-79, R42P, R33Q, K48A, V56E) were used in the study. 8 variants total.",
          "judgment": "Yes",
          "reasoning": "The study includes fewer than 11 pathogenic and benign variant controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The Q311STOP variant shows a clear pathogenic effect through multiple lines of evidence, including misfolding and aggregation, and well-established controls are used. However, due to limited statistical analysis and the total number of controls being less than 11, the strength is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": "79"
        },
        "variant_string_id": "PARK2 A1-79"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper focuses on understanding the mechanisms of parkin inactivation in autosomal recessive Parkinson's disease (ARPD). The disease mechanism involves loss of parkin function, leading to accumulation of parkin substrates and subsequent neuronal damage.",
          "judgment": "Yes",
          "reasoning": "The paper directly addresses the disease mechanism by investigating how mutations lead to loss of parkin function, a known cause of ARPD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses detergent solubility assays, cellular localization studies, and ubiquitination assays to assess the impact of mutations on protein folding, aggregation, membrane association, and E3 ligase activity. These assays are relevant for understanding how parkin mutations disrupt its normal function.",
          "judgment": "Yes",
          "reasoning": "The assays used (protein solubility, cellular localization, ubiquitination) are directly relevant to assessing parkin's function and how mutations affect it in the context of ARPD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper included wild-type parkin as a negative control and some experiments were done in triplicate, as indicated in figure legends.",
          "judgment": "Yes",
          "reasoning": "Wild-type parkin provides a normal/negative control. The text does not explicitly state replicates were performed for all experiments, but for some replicates were stated",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study uses W453Stop as a control, and also analyzes other pathogenic mutations such as A1-79.",
          "judgment": "Yes",
          "reasoning": "The paper used W453Stop and A1-79 as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "The study included quantitative analysis of the detergent-soluble and insoluble fractions, and statistical significance was not directly assessed.",
          "judgment": "No",
          "reasoning": "Statistical analyses sufficient to calculate OddsPath were not performed in the paper.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Several pathogenic variants (W453Stop, E409Stop, Q311Stop, A1-79, R42P, R33Q, K48A, V56E) were used in the study. 8 variants total.",
          "judgment": "Yes",
          "reasoning": "The study includes fewer than 11 pathogenic and benign variant controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A1-79 variant shows a clear pathogenic effect. However, due to limited statistical analysis and the total number of controls being less than 11, the strength is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "Q",
          "position": "33"
        },
        "variant_string_id": "PARK2 R33Q"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper focuses on understanding the mechanisms of parkin inactivation in autosomal recessive Parkinson's disease (ARPD). The disease mechanism involves loss of parkin function, leading to accumulation of parkin substrates and subsequent neuronal damage.",
          "judgment": "Yes",
          "reasoning": "The paper directly addresses the disease mechanism by investigating how mutations lead to loss of parkin function, a known cause of ARPD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses detergent solubility assays, cellular localization studies, and ubiquitination assays to assess the impact of mutations on protein folding, aggregation, membrane association, and E3 ligase activity. These assays are relevant for understanding how parkin mutations disrupt its normal function.",
          "judgment": "Yes",
          "reasoning": "The assays used (protein solubility, cellular localization, ubiquitination) are directly relevant to assessing parkin's function and how mutations affect it in the context of ARPD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper included wild-type parkin as a negative control and some experiments were done in triplicate, as indicated in figure legends.",
          "judgment": "Yes",
          "reasoning": "Wild-type parkin provides a normal/negative control. The text does not explicitly state replicates were performed for all experiments, but for some replicates were stated",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study used W453Stop as a control, and also analyzes other pathogenic mutations such as R33Q.",
          "judgment": "Yes",
          "reasoning": "The paper used W453Stop and R33Q as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "The study included quantitative analysis of the detergent-soluble and insoluble fractions, and statistical significance was not directly assessed.",
          "judgment": "No",
          "reasoning": "Statistical analyses sufficient to calculate OddsPath were not performed in the paper.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Several pathogenic variants (W453Stop, E409Stop, Q311Stop, A1-79, R42P, R33Q, K48A, V56E) were used in the study. 8 variants total.",
          "judgment": "Yes",
          "reasoning": "The study includes fewer than 11 pathogenic and benign variant controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The R33Q variant shows a clear pathogenic effect, however, due to limited statistical analysis and the total number of controls being less than 11, the strength is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "P",
          "position": "42"
        },
        "variant_string_id": "PARK2 R42P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper focuses on understanding the mechanisms of parkin inactivation in autosomal recessive Parkinson's disease (ARPD). The disease mechanism involves loss of parkin function, leading to accumulation of parkin substrates and subsequent neuronal damage.",
          "judgment": "Yes",
          "reasoning": "The paper directly addresses the disease mechanism by investigating how mutations lead to loss of parkin function, a known cause of ARPD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses detergent solubility assays, cellular localization studies, and ubiquitination assays to assess the impact of mutations on protein folding, aggregation, membrane association, and E3 ligase activity. These assays are relevant for understanding how parkin mutations disrupt its normal function.",
          "judgment": "Yes",
          "reasoning": "The assays used (protein solubility, cellular localization, ubiquitination) are directly relevant to assessing parkin's function and how mutations affect it in the context of ARPD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper included wild-type parkin as a negative control and some experiments were done in triplicate, as indicated in figure legends.",
          "judgment": "Yes",
          "reasoning": "Wild-type parkin provides a normal/negative control. The text does not explicitly state replicates were performed for all experiments, but for some replicates were stated",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study used W453Stop as a control, and also analyzes other pathogenic mutations such as R42P.",
          "judgment": "Yes",
          "reasoning": "The paper used W453Stop and R42P as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "The study included quantitative analysis of the detergent-soluble and insoluble fractions, and statistical significance was not directly assessed.",
          "judgment": "No",
          "reasoning": "Statistical analyses sufficient to calculate OddsPath were not performed in the paper.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Several pathogenic variants (W453Stop, E409Stop, Q311Stop, A1-79, R42P, R33Q, K48A, V56E) were used in the study. 8 variants total.",
          "judgment": "Yes",
          "reasoning": "The study includes fewer than 11 pathogenic and benign variant controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The R42P variant shows a clear pathogenic effect, however, due to limited statistical analysis and the total number of controls being less than 11, the strength is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "K",
          "alt": "A",
          "position": "48"
        },
        "variant_string_id": "PARK2 K48A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper focuses on understanding the mechanisms of parkin inactivation in autosomal recessive Parkinson's disease (ARPD). The disease mechanism involves loss of parkin function, leading to accumulation of parkin substrates and subsequent neuronal damage.",
          "judgment": "Yes",
          "reasoning": "The paper directly addresses the disease mechanism by investigating how mutations lead to loss of parkin function, a known cause of ARPD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses detergent solubility assays, cellular localization studies, and ubiquitination assays to assess the impact of mutations on protein folding, aggregation, membrane association, and E3 ligase activity. These assays are relevant for understanding how parkin mutations disrupt its normal function.",
          "judgment": "Yes",
          "reasoning": "The assays used (protein solubility, cellular localization, ubiquitination) are directly relevant to assessing parkin's function and how mutations affect it in the context of ARPD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper included wild-type parkin as a negative control and some experiments were done in triplicate, as indicated in figure legends.",
          "judgment": "Yes",
          "reasoning": "Wild-type parkin provides a normal/negative control. The text does not explicitly state replicates were performed for all experiments, but for some replicates were stated",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study used W453Stop as a control, and also analyzes other pathogenic mutations such as K48A.",
          "judgment": "Yes",
          "reasoning": "The paper used W453Stop and K48A as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "The study included quantitative analysis of the detergent-soluble and insoluble fractions, and statistical significance was not directly assessed.",
          "judgment": "No",
          "reasoning": "Statistical analyses sufficient to calculate OddsPath were not performed in the paper.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Several pathogenic variants (W453Stop, E409Stop, Q311Stop, A1-79, R42P, R33Q, K48A, V56E) were used in the study. 8 variants total.",
          "judgment": "Yes",
          "reasoning": "The study includes fewer than 11 pathogenic and benign variant controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The K48A variant shows a clear pathogenic effect, however, due to limited statistical analysis and the total number of controls being less than 11, the strength is PS3_supporting."
    },
    {
      "variant_id": {
        "Gene": "PARK2",
        "Protein_Change": {
          "ref": "V",
          "alt": "E",
          "position": "56"
        },
        "variant_string_id": "PARK2 V56E"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper focuses on understanding the mechanisms of parkin inactivation in autosomal recessive Parkinson's disease (ARPD). The disease mechanism involves loss of parkin function, leading to accumulation of parkin substrates and subsequent neuronal damage.",
          "judgment": "Yes",
          "reasoning": "The paper directly addresses the disease mechanism by investigating how mutations lead to loss of parkin function, a known cause of ARPD."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses detergent solubility assays, cellular localization studies, and ubiquitination assays to assess the impact of mutations on protein folding, aggregation, membrane association, and E3 ligase activity. These assays are relevant for understanding how parkin mutations disrupt its normal function.",
          "judgment": "Yes",
          "reasoning": "The assays used (protein solubility, cellular localization, ubiquitination) are directly relevant to assessing parkin's function and how mutations affect it in the context of ARPD pathogenesis.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper included wild-type parkin as a negative control and some experiments were done in triplicate, as indicated in figure legends.",
          "judgment": "Yes",
          "reasoning": "Wild-type parkin provides a normal/negative control. The text does not explicitly state replicates were performed for all experiments, but for some replicates were stated",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "The study used W453Stop as a control, and also analyzes other pathogenic mutations such as V56E.",
          "judgment": "Yes",
          "reasoning": "The paper used W453Stop and V56E as controls.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "The study included quantitative analysis of the detergent-soluble and insoluble fractions, and statistical significance was not directly assessed.",
          "judgment": "No",
          "reasoning": "Statistical analyses sufficient to calculate OddsPath were not performed in the paper.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "Several pathogenic variants (W453Stop, E409Stop, Q311Stop, A1-79, R42P, R33Q, K48A, V56E) were used in the study. 8 variants total.",
          "judgment": "Yes",
          "reasoning": "The study includes fewer than 11 pathogenic and benign variant controls.",
          "next_step_or_outcome": "The functional evidence strength is Max PS3_supporting / Max BS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The V56E variant shows a clear pathogenic effect, however, due to limited statistical analysis and the total number of controls being less than 11, the strength is PS3_supporting."
      }
    }
  ]
}
```